UBS: Palantir Valued Below AI Software Peers, Price Target Raised to $250
nashnova research
UBS lifted its Palantir target from $220 to $250, implying 44% upside; the analyst sees this AI-software leader as paradoxically cheaper than peers — a "relatively inexpensive" entry point.
What exactly did UBS see in Palantir?
Analyst Karl Keirstead attended Palantir's AIPCon event last week, speaking directly with executives and customers.
His core call: Palantir is the "best AI enabler in the market" — uniquely able to connect frontier models to real enterprise workflows.
This means → UBS isn't betting on Palantir's own models. It's betting on Palantir's ability to make AI work for large organizations — the scarcest link in the enterprise AI chain.
Highest growth, yet a lower valuation — why?
Palantir trades at 51× estimated 2027 free cash flow. That sounds expensive.
But Keirstead notes it has the "highest growth rate and margins" in the software sector, yet trades below Snowflake, CrowdStrike, and other AI-software peers.
In plain terms = the top student in class is somehow selling at a discount to classmates with lower grades.
This reflects two market fears: ① growth may be peaking, and ② foundation-model providers could move into the data-software layer and compete directly.
Down 3% year-to-date — what happened?
Palantir has fallen roughly 3% in 2025, pressured by profit-taking on a stretched valuation and a broader summer tech-sector rotation.
Zoom out, though: the stock rose 167% in 2023, 340% in 2024, and 135% in 2025 — a staggering three-year run.
This means → the year-to-date dip looks more like a breather after three consecutive blowout years than a fundamental shift.
Where does Wall Street stand — is UBS an outlier?
Per LSEG data, 23 of 33 analysts rate Palantir a buy or strong buy.
UBS's call aligns with broad Street consensus — it is not an isolated bullish voice.
The key checkpoint ahead: whether upcoming earnings can disprove the "peak growth" narrative. If revenue acceleration holds, the valuation discount has room to narrow.
市场有风险，内容仅供研究参考，不构成投资建议。